Our results indicate that the blockade of IL-36 signaling in the TNF-mouse model has no key impact on the pathogenic course of TNF-induced arthritis and therefore does not protect from TNF-induced inflammation and bone loss. The gene discussed is TNF; the disease is Arthritis.